These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 17561971)

  • 21. [Constitutional deficiency in antithrombin III].
    Guenneguez H; Ouvry PA
    Phlebologie; 1985; 38(3):421-4. PubMed ID: 4059343
    [No Abstract]   [Full Text] [Related]  

  • 22. Gene symbol: SERPINC1. Disease: Antithrombin deficiency. Accession #Hd0514.
    Schleithoff L; Seelig HP
    Hum Genet; 2006 Feb; 118(6):775. PubMed ID: 17297683
    [No Abstract]   [Full Text] [Related]  

  • 23. [Thrombophilia in a patient with congenital deficiency of AT III].
    Miljić P; Colović M; Stanojević M; Elezović I; Bosković D
    Srp Arh Celok Lek; 1994; 122(11-12):344-6. PubMed ID: 17974415
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Antithrombin deficiency due to heterozygous antithrombin gene mutation and a pedigree study].
    Ye X; Feng Y; Jin PP; Zhou XH; Ding QL; Wang XF
    Zhonghua Xue Ye Xue Za Zhi; 2007 Sep; 28(9):587-9. PubMed ID: 18246812
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Familial thrombosis in a Dutch faily: inherited deficiency of antithrombin III.
    Vellenga E; Mulder NH; Marrink J; Nieweg HO
    Neth J Med; 1980; 23(4):149-51. PubMed ID: 7453908
    [No Abstract]   [Full Text] [Related]  

  • 26. The relationship between defective heparin cofactor activities and thrombotic phenomena in AT III abnormalities.
    Girolami A; Lazzaro AR; Simioni P
    Thromb Haemost; 1988 Feb; 59(1):121. PubMed ID: 3363528
    [No Abstract]   [Full Text] [Related]  

  • 27. [Genetic analysis of congenital antithrombin deficiencies].
    Masuda H; Tsuji H; Nakahara Y; Nishimura H; Kasahara T; Sugano T; Nakagawa M
    Rinsho Byori; 1997 Feb; Suppl 104():187-94. PubMed ID: 9128381
    [No Abstract]   [Full Text] [Related]  

  • 28. High long-term absolute risk of recurrent venous thromboembolism in patients with hereditary deficiencies of protein S, protein C or antithrombin.
    Brouwer JL; Lijfering WM; Ten Kate MK; Kluin-Nelemans HC; Veeger NJ; van der Meer J
    Thromb Haemost; 2009 Jan; 101(1):93-9. PubMed ID: 19132194
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antithrombin--early prophecies and present challenges.
    Abildgaard U
    Thromb Haemost; 2007 Jul; 98(1):97-104. PubMed ID: 17597998
    [No Abstract]   [Full Text] [Related]  

  • 30. [Neonatal arterial thrombosis and anti-thrombin III deficiency].
    Pérez Aragón AJ; Gutiérrez Pimentel MJ; Samaniego Muñoz M; García Róspide F; Corral de la Calle J
    An Pediatr (Barc); 2008 Jan; 68(1):70-1. PubMed ID: 18194632
    [No Abstract]   [Full Text] [Related]  

  • 31. Role of antithrombin concentrate in treatment of hereditary antithrombin deficiency. An update.
    Rodgers GM
    Thromb Haemost; 2009 May; 101(5):806-12. PubMed ID: 19404531
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment for antithrombin deficiency in the real world.
    Favaloro EJ
    Int J Lab Hematol; 2011 Dec; 33(6):656-8; author reply 659-60. PubMed ID: 21668656
    [No Abstract]   [Full Text] [Related]  

  • 33. Early intervention with antithrombin III therapy to prevent progression of hepatic venoocclusive disease.
    Peres E; Kintzel P; Dansey R; Baynes R; Abidi M; Klein J; Ibrahim RB; Abella E
    Blood Coagul Fibrinolysis; 2008 Apr; 19(3):203-7. PubMed ID: 18388499
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thrombophilia of nephrotic syndrome in adults.
    Bramham K; Hunt BJ; Goldsmith D
    Clin Adv Hematol Oncol; 2009 Jun; 7(6):368-72. PubMed ID: 19606070
    [No Abstract]   [Full Text] [Related]  

  • 35. VTE recurrence in patients with inherited deficiencies of natural anticoagulants.
    Dentali F; Gianni M
    Thromb Haemost; 2009 Jan; 101(1):5-6. PubMed ID: 19132180
    [No Abstract]   [Full Text] [Related]  

  • 36. The inefficacy of enoxaparin prophylaxis in a patient with congenital antithrombin deficiency.
    Tomkowski WZ; Dybowska M; Kuca P; Gralec R; Burakowski J
    Clin Appl Thromb Hemost; 2009; 15(2):241. PubMed ID: 19357104
    [No Abstract]   [Full Text] [Related]  

  • 37. [Congenital antithrombin III deficiency].
    Ohke M
    Ryoikibetsu Shokogun Shirizu; 1996; (15):460-3. PubMed ID: 9048069
    [No Abstract]   [Full Text] [Related]  

  • 38. [Progression from a routine examination to a study. Having come this far, what should be done from now? A thrombosis risk factor study].
    Suehisa E
    Rinsho Byori; 2008 Oct; 56(10):924-9. PubMed ID: 19068790
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mitochondrial oxidative phosphorylation disorders presenting in neonates: clinical manifestations and enzymatic and molecular diagnoses.
    Gibson K; Halliday JL; Kirby DM; Yaplito-Lee J; Thorburn DR; Boneh A
    Pediatrics; 2008 Nov; 122(5):1003-8. PubMed ID: 18977979
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acquired angioedema associated with primary antiphospholipid syndrome in a patient with antithrombin III deficiency.
    Széplaki G; Varga L; Szépvölgyi A; Simon K; Blaskó B; Nagy E; Karádi I; Füst G; Farkas H
    Int Arch Allergy Immunol; 2008; 146(2):164-8. PubMed ID: 18204284
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.